Isopropyl alcohol Recruiting Phase 2 Trials for Acute Bilineal Leukemia / Refractory Acute Myeloid Leukemia / acute, recurrent Myeloid Leukemia / Chronic Myelomonocytic Leukemia / Myelodysplastic Syndrome / Acute Biphenotypic Leukemia (ABL) / IDH2 Gene Mutation Treatment

Indications	Status	Purpose	Phase
DBCOND0114136 (Acute Bilineal Leukemia) DBCOND0036504 (Refractory Acute Myeloid Leukemia) DBCOND0112369 (acute, recurrent Myeloid Leukemia) DBCOND0028572 (Chronic Myelomonocytic Leukemia) DBCOND0028333 (Myelodysplastic Syndrome) DBCOND0081399 (Acute Biphenotypic Leukemia (ABL)) DBCOND0089570 (IDH2 Gene Mutation)	Recruiting	Treatment	2

clinicaltrials.gov Identifier	Title	Drugs
NCT03683433	Enasidenib and Azacitidine in Treating Patients With Recurrent or Refractory Acute Myeloid Leukemia and IDH2 Gene Mutation	Doxazosin (DB00590) Isopropyl alcohol (DB02325) Enasidenib (DB13874) Azacitidine (DB00928)